With links to Cochlear, the US-based med-tech company has global ambitions for its spinal cord stimulator technology.

Saluda Medical lists this Friday with the remit of tackling chronic pain with its Evoke spinal cord stimulation device.

OverviewThe global neurotech devices market is experiencing strong momentum and is projected to grow at a CAGR of approximately 13% over the forecast period. This growth trajectory is shaped by ...

The growth of the global bioelectric medicine market is propelled by various drivers including the increasing population of the geriatric group, rising burden of diseases necessitating the use of ...

O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ...

Spinal cord injury (SCI) rostral to the lumbar locomotor center disrupts communication between the brain and the spinal ...

Abbott Laboratories could be looking to acquire Exact Sciences, according to a report from Bloomberg, citing people close to the deal. News of the rumored deal caused Madison, WI-based Exact Sciences ...

The pharmaceutical and medical device industries stand at an inflection point. After decades of reliance on traditional ...

Mordor Intelligence has published a new report on neuromodulation market offering a comprehensive analysis of trends, growth drivers, and future projections.

Exact Sciences Corporation stock surged after Abbott Laboratories announces a $21bn acquisition at $105 per share, driven by Exact's cancer diagnostics leadership. Exact Sciences boasts strong revenue ...